Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs Sunrun Inc (RUN) Price & Performance

Humana IncTrade
Sunrun IncTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs Sunrun Inc — how do they compare? Humana Inc trades at $432 (market cap $46.49B), while Sunrun Inc trades at $7.55 (market cap $1.83B). The key difference: Humana Inc is far larger — about 25.4× Sunrun Inc's market cap, and Humana Inc pays a 0.91% dividend while Sunrun Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Sunrun Inc for 16 Days on average.

HUMRUN
Market Cap
$46.49B$1.83B
Volume
2,567,7048,672,852
Sector
HealthEnergy
52-Week High
$409.85$21.41
52-Week Low
$163.67$7.59
Typical Hold Time
51 Days16 Days
Enterprise Value
$53.84B$16.35B
Dividend Yield
0.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $436.00, up 9.96% in the last 24 hours, with a bullish technical signal and strong earnings beats in recent quarters. Revenue has grown to $129.66 billion in 2025, though net income margin compressed to 0.88%. Analyst consensus is a buy with a $457.05 price target, and recent news highlights a Barclays upgrade and dividend declaration.

The outlook is positive given earnings momentum and institutional interest, but risks include margin pressure and regulatory scrutiny. Upside potential exists if the company maintains enrollment growth and cost controls, though investors should monitor Medicare Advantage plan changes and competitive dynamics.

Sunrun Inc

Sunrun (RUN) trades at $7.58, down 0.39% on the day, reflecting a bearish technical trend. The stock shows attractive valuation ratios with a P/E of 5.16 and P/S of 0.59, while recent quarterly earnings have consistently beaten expectations. However, cash flow from operations remains negative, and the company faces headwinds from high borrowing costs impacting the solar sector. Positive developments include a record 580 MW grid dispatch with Tesla and expanded partnerships for distributed computing.

The outlook is mixed: strong analyst support with a $16.33 price target suggests significant upside, but operational cash burn and sector volatility pose risks. Investors should weigh low valuations against execution challenges and macroeconomic pressures affecting solar financing.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUM
93% Buy7% Sell
Avg holding period · 51 Days
RUN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →

About Sunrun Inc

Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.

Read more on RUN →